A study at Uppsala University has recently shown the potential of an anti-inflammatory cytokine for Type 1 diabetics.
Researchers have been experimenting with islet cell transplantation as a possible cure for Type 1 diabetes for decades. These insulin-producing cells are destroyed by Type 1 diabetes, but various transplant methods that worked in animals--including using tiny capsules to deliver the cells in a way that guards against an immune response--have failed to make the grade in humans.
Johnson & Johnson's Janssen unit is teaming up with nonprofit JDRF to develop new diagnostic approaches for Type 1 diabetes, aiming to identify the disease earlier and curb its progression.
Scientists from Harvard University have developed a technique that coaxes embryonic stem cells into fully functioning human insulin-producing beta cells, possibly paving the way for less invasive and more permanent treatment options for Type 1 diabetes.
The FDA has signed off on a new, highly specific biomarker blood test designed by an Idaho company to quickly spot Type 1 diabetes.
Scientists have identified a key pathway for a gene that dictates a person's predisposition to Type 1 diabetes, a finding that could lead to new treatments for the prevention and control of diabetes and possibly other metabolic-associated diseases.
Investigators at the University of Cincinnati have used an experimental therapy to essentially reverse the onset of Type 1 diabetes in mouse models.
Low doses of a cancer drug may be able to act as a preventive drug against the development of Type 1 diabetes, according to new findings.
Investigators at the Harvard Stem Cell Institute have discovered a hormone with the ability to produce beta cells--the insulin-producing cells found in the pancreas that are lost in diabetes--that could potentially treat type 2 diabetes more effectively.
Doctors have identified several newer biomarkers that appear to predict the onset of a damaging, diabetes-related kidney complication.